Showing results (1-10 of 1,470) with videos related to
Sort By:
Pageof 147
Cell Death and Differentiation|August 2, 2003
CD95 ligand--death factor and costimulatory molecule?O Janssen, J Qian, A Linkermann, et al.Frontiers in Bioscience : a Journal and Virtual Library|February 15, 1997
Antigen-induced death of T-lymphocytesD Kabelitz, O JanssenCellular Immunology|April 15, 1989
Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expressionD Kabelitz, O JanssenJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1988
Tumor necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virusO Janssen, D KabelitzEuropean Journal of Immunology|January 1, 1990
In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell cloneO Janssen, S Gillis, D KabelitzCell and Tissue Research|August 6, 2000
Regulation of activation-induced cell death of mature T-lymphocyte populationsO Janssen, R Sanzenbacher, D KabelitzBlood|May 1, 1989
T cells in B-cell chronic lymphocytic leukemia: quantitative assessment of cytotoxic and interleukin-2-producing lymphocyte precursors by limiting dilution analysisO Janssen, C Nerl, D KabelitzJournal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
SLP-76 binding to p56lck: a role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complexR Sanzenbacher, D Kabelitz, O JanssenArzneimittel-Forschung|November 1, 1993
In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis)O Janssen, A Scheffler, D KabelitzJournal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cellsS Wesselborg, O Janssen, D KabelitzPageof 147